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Background: Recent efforts to curtail the HIV epidemic in Africa have emphasised preventing sexual transmission
to partners through antiretroviral therapy. A component of current strategies is disclosure to partners, thus
understanding its motivations will help maximise results. This study examines the rates, dynamics and
consequences of partner disclosure in Burkina Faso, Kenya, Malawi and Uganda, with special attention to the role of
support groups and stigma in disclosure.
Methods: The study employs mixed methods, including a cross-sectional client survey of counselling and testing
services, focus groups, and in-depth interviews with HIV-positive individuals in stable partnerships in Burkina Faso,
Kenya, Malawi and Uganda, recruited at healthcare facilities offering HIV testing.
Results: Rates of disclosure to partners varied between countries (32.7% – 92.7%). The lowest rate was reported in
Malawi. Reasons for disclosure included preventing the transmission of HIV, the need for care, and upholding the
integrity of the relationship. Fear of stigma was an important reason for non-disclosure. Women reported
experiencing more negative reactions when disclosing to partners. Disclosure was positively associated with living
in urban areas, higher education levels, and being male, while being negatively associated with membership to
support groups.
Conclusions: Understanding of reasons for disclosure and recognition of the role of support groups in the process
can help improve current prevention efforts, that increasingly focus on treatment as prevention as a way to halt
new infections. Support groups can help spread secondary prevention messages, by explaining to their members
that antiretroviral treatment has benefits for HIV positive individuals and their partners. Home-based testing can
further facilitate partner disclosure, as couples can test together and be counselled jointly.
Keywords: Disclosure, HIV counselling and testing, Support groups, Stigma, HIV/AIDS, Mixed methodsBackground
The coverage of antiretroviral treatment (ART) [1] in
Sub-Saharan Africa has expanded significantly in recent
years. New guidelines for eligibility and recent evidence
showing the public health benefits of early ART initi-
ation in preventing onward transmission [2-5] have led
to a prioritization of testing to diagnose patients at earlier* Correspondence: a.p.hardon@uva.nl
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reproduction in any medium, provided the orstages of HIV infection. Key issues for treatment as pre-
vention programs include outreach to key populations
and disclosure among sero-discordant couples.
Within HIV counselling and testing programs, HIV-
positive individuals are generally actively encouraged
to disclose to their partners. Despite this advice, dis-
closure to partners remains sub-optimal in many set-
tings in Sub-Saharan Africa [6,7], with a significant
proportion of HIV-positive individuals waiting over a
year to inform their partners [8,9]. Rates of disclosureLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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kind of testing facility [10-14].
Although studies have found that health facilities offer-
ing HIV testing in Sub-Saharan Africa are trying to ac-
commodate the needs of couples, uptake remains a
challenge, with a low number of couples testing together
[15]. Nevertheless, some studies have reported success in
increasing testing among couples [16], in particular
through home-based testing [17,18], while one recent
study on HIV testing within routine health services [19]
reported high rates of partner referral in post-test
counselling.
Fear of enacted stigma – including violence, aban-
donment and divorce – negatively affects rates of
partner disclosure [8,15,20-25]. The Multi-Country
African Testing and Counselling for HIV (MATCH)
study [19] conducted in Burkina Faso, Kenya, Malawi
and Uganda found that despite the emphasis on part-
ner disclosure in post-test counselling, only 37% of
the HIV-positive women tested within Prevention of
Mother-to-Child Transmission (PMTCT) programmes
had disclosed to their partners. When they did so,
disclosure often led to serious rifts, including aban-
donment and divorce. Men disclosed more often and
experienced less negative consequences upon disclo-
sing than women [26]. Partner disclosure requires
trust that the intimate other will provide care and will
not contribute to the stigmatization of the affected
individual.
Small-scale ethnographic studies suggest that HIV-
positive individuals find it easier to disclose to other
HIV-positive persons in support groups or in clinics
than to their partners. These studies also suggest that
HIV-positive individuals often pursue strategies of incre-
mental, partial or indirect disclosure, which in some
cases allow their partners to disclose first [27-29].
The current study employs mixed methods to explore
the dynamics and consequences of partner disclosure in
Burkina Faso, Kenya, Malawi and Uganda. In doing so, it
integrates data from the qualitative and quantitative
components of the MATCH study [30].
Methods
The cross-sectional MATCH study was designed to
compare client experiences of different HIV testing
services in Burkina Faso, Kenya, Malawi and Uganda. It
was conducted in 2008-09, after ART programs had been
scaled up in all four countries. The MATCH study’s
methods have been reported in detail elsewhere [19]. In all
four countries, HIV counselling and treatment (HCT)
policies emphasize partner disclosure.
The MATCH study was based on a main survey
(including open-ended questions on disclosure and its
consequences) of clients at health facilities offering HCTin the capital region and one rural province/district in
each country. Health facilities were purposefully selected
and consisted of: (1) integrated facilities (hospitals and
medical facilities providing both provider- and client-
initiated testing alongside medical services); (2) antenatal
clinics and other facilities offering care to pregnant
women; and (3) standalone facilities for HCT.
Potential participants were randomly approached at
the study sites. After receiving their informed consent,
field interviewers administered face-to-face question-
naires including multiple choice and open-ended ques-
tions (n = 3,659). The collected data included
respondents’ socio-demographic characteristics, reported
HIV status, time elapsed since learning their status, their
experiences with HIV counselling and testing and partner
disclosure, as well as reported experiences of self- and
enacted stigma. To triangulate the information collected
through the survey’s open-ended questions, we conducted
102 in-depth interviews with key informants recruited
through support groups for HIV-positive individuals. To
gain further insight into the lives of HIV-positive persons,
experienced qualitative researchers conducted 20 focus
group discussions with support group members.
Qualitative analysis
To assess the dynamics and consequences of partner
disclosure and to develop hypotheses on its determi-
nants, we analysed the partner disclosure narratives of
157 HIV-positive individuals contained in the responses
to the survey’s open-ended questions (see Table 1 for
their demographic characteristics). For each respondent,
we wrote a case summary citing their reasons for being
tested, whether health workers had encouraged them to
disclose, their reasons to disclose to their partner, reac-
tions to disclosure from their partner, their experiences
of self-stigma, and whether they had joined a support
group. Insights into the dynamics of disclosure were also
derived from in-depth interviews and focus group dis-
cussions in all four countries, which were analysed with
NVivo 8 software.
Quantitative analysis
Our quantitative analysis focused on the subset of
MATCH participants who reported being tested, who
were aware of being HIV-positive for more than one
week, and who identified themselves as married or
cohabiting. The dependent variable was self-reported
disclosure to partners.
Of the total sample, 69.8% of respondents (n = 2,553/
3,659) responded affirmatively to the question whether
they had ever had an HIV test. Of those who had tested in
or after 2007 and knew their HIV status, 28.1% (n = 602/
2,146) reported being HIV-positive; 83.9% of this latter
group (n = 505/602) had been aware of their sero-status
Table 1 Demographic characteristics of missing records compared to the original sample
Variable All (n = 281) Records excluded (n = 50)
Gander, Female: Male, n (%) 174 (68.1): 107 (31.9) 27 (54): 23 (46)
Age, mean (SD) 34.5 (9.1) 35.1 (9.6)
Education, <primary: > = primary, n (%) 146 (51.9): 135 (48.1) 24 (48): 26 (52)
Country Malawi, n (%) 114 (40.6) 13 (26.0)
Kenya, n (%) 74 (26.3) 11 (22.0)
Uganda, n (%) 51 (18.2) 19 (38.0)
Burkina Faso, n (%) 42 (14.9) 7 (14.0)
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(55.6%, n = 281/505) identified themselves as married or
cohabiting (Figure 1). After excluding 50 (17.8%) indivi-
duals with missing data on disclosure to their partners,
our sample included 231 individuals. We provide aFigure 1 Participant selection. This figure shows the selection
process of participants. From the total sample of 3,659, we excluded
people in the following order: (1) participants lacking information on
their testing status or who were never tested; (2) participants who
tested before 2007; (3) participants lacking information on their
sero-status; (4) participants who were HIV-negative or were unwilling
to discuss their sero-status; (5) participants who knew their sero-status
for less than one week; (6) participants not currently married and/or
cohabiting; (7) participants lacking information or not willing to discuss
disclosure to their partners. n, refers to number of participants; missing
value/don't know refers to participants who did not answer the
relevant question or answer not being aware of that information;
>1 week, duration more than one week.description of demographic data of missing records in
Table 1.
The determinants of partner disclosure to be tested
were defined by the results of the analysis of the open-
ended answers of 90 HIV-positive women and 67 HIV-
positive men (see above section on qualitative analysis).
These included: (1) individual characteristics (gender, age,
education, recruited in a rural or urban area, and the
presence of symptoms requiring HIV testing or treatment
at one’s most recent test); and (2) membership in support
groups and (3) experiences of stigma. All were included as
categorical variables, except for age which was included as
a continuous variable.
We did not include measures of enacted stigma in our
quantitative analysis as our qualitative findings suggested
that it could be both a determinant of non-disclosure
and a consequence of disclosure. Understanding the re-
lationship between enacted stigma and disclosure would
require a longitudinal study. We did, however, examine
(fear of ) enacted stigma in our qualitative analysis.
We expected self-stigma to affect disclosure – as had
been reported in other studies [12,13,31] – and included
self-stigma (inner feelings of worthlessness and/or guilt)
in our quantitative analysis. We created a dichotomous
variable for reported self-stigma, based on a positive
response to either of two questions: “I sometimes feel
worthless because I am HIV-positive” and “I feel guilty be-
cause I have HIV”. We derived this definition of self-
stigma from the World Health Organization’s manual HIV
Testing, Treatment and Prevention: Generic Tools for
Operational Research [32].
Membership of support groups was self-reported. We
ran tests of bivariate associations and modified Poisson
regressions to assess significance and to estimate the
unadjusted and adjusted associations between selected de-
terminants and the dependent variable [33]. The first
multivariate model included each determinant and coun-
try of recruitment. A second multivariate model included
all variables significant at p-value < 0.05 in the univariate
analysis and country of recruitment. We analysed the data
using Stata/SE 11.2.
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Committee of the World Health Organization, and by
an Institutional Review Board (IRB) in each of the four
countries (the Comité d’Ethique pour la Recherche en
Santé of the Ministries of Health and Higher Education in
Burkina Faso; the Institutional Review Board of Kenyatta
National Hospital in Kenya; the National Health Science
Research Committee of the Ministry of Health and Popu-
lation in Malawi; and the Institutional Review Board of
the National Council for Science and Technology of
Makerere University in Uganda).Results and discussion
The analysis of participant (90 female and 67 male)
responses to the survey’s open-ended questions pointed
to three main reasons for disclosing in all four countries:
(1) prevention, including the intention to use condoms
and/or encourage one’s partner to get tested (reported
more often by women); (2) to receive care and support
from one’s partner (reported more often by men); and
(3) the intimate nature of the relationship (mentioned by
both men and women).
The logic of prevention informed the decision to disclose
for many respondents. A 33 year-old Malawian woman
diagnosed in antenatal care said she disclosed after being
advised to do so by healthcare workers; she wanted her
husband to be tested as well. She had expected to receive a
positive diagnosis since her husband had multiple wives.
She experienced stigma in the past when she was told to
eat alone. She joined a support group. A 28 year-old
Malawian woman tested at a VCT centre said she disclosed
to her husband because she wanted him to accept using
condoms. Her husband had encouraged her to get tested.
Referring to her husband’s reaction, she says, “He was
happy that I made the decision to get tested, we are both on
ART and living happily”. She has experienced stigma when
people were laughing at her. A 51 year-old man in Burkina
Faso tested in a standalone VCT facility in urban
Dédougou, because he had lived with a girlfriend who had
tested positive and had subsequently died. Health workers
had not encouraged him to disclose to his current wife.
Before he received his results he told his wife to get tested,
while she tested negative his results were positive. He de-
cided to disclose to his new wife to protect her: “I could
not hide it from her. It is to save her, that’s why I told her”.
Some respondents disclosed to their partners so that
they could receive the care they needed. A 58 year-old
married man in Uganda was routinely tested for HIV
when he was admitted in a rural hospital for TB. It was
difficult for him to be tested; “I thought that when I was
told my HIV results I would die immediately”. He was
not encouraged by health workers to disclose. While he
feared disclosing because he feared that his wife wouldleave him he decided to disclose to his partner and
brother “to get support and care from them”.
Others referred to the intimacy of their relationships.
A 37 year-old woman from Burkina Faso had tested ini-
tially since she was suffering from regular bouts of mal-
aria. She was not encouraged by a health worker to
disclose but said she wanted to tell her husband because
“although we have no children we have been together for
two years”. In the absence of children, who are an im-
portant element for a woman’s social standing, this
woman valued the relatedness to her husband. There
were varied ways how the respondents describe the in-
timacy of their relationship, some simply commented
that they disclosed “because we are living together”.
Others stated that their partners “deserved to know the
truth” such as a married 43 year old Ugandan man who
tested at a standalone VCT center in rural Soroti. He did
not discuss going for a test with his wife beforehand.
The health workers told him not to be ashamed and
encouraged him to disclose. He disclosed to his wife;
“It’s because her being my wife I had to tell her the
truth”.
Consequences of disclosure
The analysis of disclosure narratives revealed that accep-
tance of a partner’s HIV status is a gradual process. While
the initial reaction was often one of shock and disbelief,
most partners grew more supportive over time. A 27 year-
old married woman from Kenya explained that she was
tested for HIV when she was pregnant. Her husband at
first did not believe the result: “He was shocked and could
not believe it. We both went to test together”. After he was
tested, he became more supportive and encouraging. A
28 year-old married woman from Uganda was admitted
with fever to the Mulago TB ward where she was encour-
aged to test for HIV. She could not believe that she was
HIV-positive because she had been faithful to her partner.
Although health workers did not encourage her to dis-
close, she decided to tell her parents and husband “so that
he could also go and test so that we can plan and look
after our children”. Though his initial reaction was
discouraging, it improved over time: “He felt bad,
condemned me that I was the one who brought the infec-
tion. [But later] he gave me money for treatment and
transport”.
The 157 partner disclosure narratives revealed that
partners’ initial reactions can vary tremendously.
Negative responses ranged from disbelief and denial,
blaming the spouse for infidelity and bringing the dis-
ease into the family, to violence, separation and divorce.
In some cases there was a complete absence of reaction,
interpreted as indifference. But when respondents de-
scribed supportive responses, they described their part-
ners as “understanding” and “loving”.
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90 women reported receiving negative reactions, which
was the case for only 7 out of 67 men (four in Kenya,
two in Uganda, and one in Malawi). A 37 year-old
woman in Burkina Faso chose to disclose to her husband
because she wanted him to get tested. When she told
him, he shook his head, left her with their children, and
cut off his support. When his new wife arrived, the
respondent had to move in with her uncle. She reported
that her ex-husband had told his new wife that she had
“walked with other men”, which had given her the
disease, but that he was healthy.
One of the Kenyan men who suffered a negative
response from his partner was a 34 year-old who tested
for HIV when he was being treated for a sexually trans-
mitted infection. Health workers encouraged him to dis-
close to his wife, with whom he had been living for five
years. When he did so, she accused him of infidelity,
saying he had “gotten infected elsewhere”. They have
since divorced. The divorce, alongside knowing that he
“cannot marry again”, has been the most difficult thing
so far about living with HIV.
Reasons for non-disclosure
In explaining their decisions not to disclose, most respon-
dents alluded to the fear of enacted stigma. A 38 year-old
man from Malawi, was tested in Mitundu Rural Hospital
because he wanted to know his status since he was falling
sick often, he discussed going for a test with his wife be-
forehand but he did not disclose his results because he
wanted “to avoid social abuse”. A 27 year-old woman in
Burkina Faso who went to a VCT centre to get tested be-
cause of her husband’s sexual behaviour reasoned simi-
larly: “If you tell them that you have the disease, they will
reveal your name. If you have a co-wife and she learns that
you have the disease, it will cause you harm”. In Uganda, a
19 year-old woman who was routinely tested for HIV
when she was pregnant had known her status for two and
a half months at the time of the interview and did not dis-
close because “My husband would divorce me even if he
were to know that he is infected”.
Interestingly, three men in Burkina Faso reported that
they had been advised at three different testing facilities
(two at VCT centres and one at an integrated health
facility) to not disclose their test results. A 68 year-old
man who had tested at a standalone VCT facility in
urban Dédougou stated that he had not disclosed
“because we were given advice there that everyone has to
keep his findings secret. That’s why I have not spoken to
anyone, even my wife”.
The role of support groups
Support groups can provide HIV-positive individuals with
information on how to disclose to their partners. Ourinterviews with key informants revealed that support
groups can also counsel confidentiality. Many support
groups seem to advocate selective and timely disclosure.
Members of support groups whom we interviewed
reported:
In the support group meetings, we have been told that
you don’t have to disclose if you are not ready. But it
is good to disclose if you want to (woman, mid-40s,
Kenya).I learnt from the support group that disclosure is a
process. It is not a one-time event. If I had known this
before, I would not have disclosed to my wife so soon.
If I had done it more gradually, the impact would not
have been that bad. If you don’t take time to disclose,
and just tell someone that you are positive, like I did
with my wife, the person will think that you are about
to die. He will even think that sharing food with you
will infect them with HIV (man, 44 years, Kenya).I have not told anyone yet. The only people who know
are the support group members. I have not told my
children but they know that I take medicine daily. I
have not told anyone because if you tell people they
will just stigmatize you (woman, 30 years, Kenya).
Male support group members in a focus group in
urban Malawi argued that their membership was already
a form of disclosure. As one respondent explained:
I didn’t disclose to anybody because I don’t know their
status, why should I trouble myself in disclosing mine
to people who would not respect me? But because I am
a member of a support group here at least they know
my sero-status.Quantitative results
We used our qualitative findings to develop hypoth-
eses on the determinants of disclosure. The following
section describes our quantitative analysis of these
hypotheses.
As shown in Table 2, the majority of participants in
our sample (N = 231) were women (63.6%, n = 147/
231). The average age was 34.4 years. Almost half
(47.2%, n = 109/231) reported having finished at least
primary education. The majority were recruited in
urban or peri-urban settings (58.1%, n = 133/229). The
overall rate of reported self-stigma was 23.1% (n = 52/
227). Almost three-quarters of our respondents did not
report any symptoms requiring testing or treatment for
HIV at the time of their last test (71.5%, n = 163/228).
60.6% of respondents [95% CI 54.0-67.0] (n = 140/231)
Table 2 Sample (n = 231)
Variable N (%) Disclosure,
n (%)
All 231 (100) 140 (60.6)
Gender female 147 (63.6) 77 (52.4)
male 84 (36.4) 63 (75.0)
Age mean (SD) 34.4 (9.0) 35.3 (9.2)**
Education <primary 122 (52.8) 60 (49.2)
> = primary 109 (47.2) 80 (73.4)
Setting of recruitment rural 96 (41.9) 39 (40.6)
urban 133 (58.1) 113 (72.9)
Presence of symptoms requiring treatment at most
recent test*
no 163 (71.5) 106 (65.0)
yes 65 (28.5) 32 (49.2)
Self-stigma* no 173 (76.9) 103 (59.5)
yes 52 (23.1) 37 (71.2)
Membership in support groups* no 155 (68.9) 113 (72.9)
yes 70 (31.1) 27 (38.6)
Country of recruitment Malawi 101 (43.7) 33 (32.7)
Kenya 55 (23.8) 51 (92.7)
Uganda 40 (17.3) 31 (77.5)
Burkina Faso 35 (15.2) 25 (71.4)
Legend: N = number of participants in each group; n = number of participants reporting disclosure to their partners; SD = standard deviation;
<primary: incomplete primary education or no education; > = primary: complete primary education and above. *Values do not add up to overall total
due to missing values. **mean and standard deviation of those disclosing to partners.
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all reported disclosing to someone.
Partner disclosure levels in Kenya, Uganda and
Burkina Faso were much higher at 92.7% (n = 51/55,
p < 0.001), 77.5% (n = 31/40, p < 0.001) and 71.4%
(n = 25/35, p < 0.001) respectively than in Malawi, at
only 32.7% (n = 33/101).
Determinants of disclosure
Table 3 shows the determinants of disclosure to part-
ners. In univariate analysis, men were more likely to
disclose (uRR 1.43 [95% CI 1.18-1.75], p < 0.001), as
were older respondents (uRR 1.01 [95% CI 1.00-1.02], p =
0.042). Respondents recruited in urban settings were more
likely to disclose (uRR 1.85 [95% CI 1.43-2.40], p < 0.001)
than those recruited in rural settings.
Membership in support groups was strongly asso-
ciated with not disclosing to partners (uRR 0.53 [95% CI
0.39-0.72], p < 0.001). Having symptoms requiring fur-
ther diagnosis or treatment at one’s most recent test
was also associated with non-disclosure to partners,
though the association is less strong (uRR 0.76 [95% CI
0.58-0.99], p < 0.001).
In multivariate analysis, country of recruitment remained
associated with disclosure rates. Participants from Kenya,Burkina Faso and Uganda reported significantly higher
rates of disclosure to partners than in Malawi. Membership
in support groups, presence of symptoms requiring
treatment, and age remained associated with disclosure
(aRR 0.67 [95% CI 0.51-0.88], p = 0.004; aRR 0.75 [95%
CI 0.58-0.98], p = 0.032; and aRR 1.01 [95% CI 1.00-1.02],
p = 0.030 respectively).
Discussion
Our findings show that partner disclosure rates in times
of treatment scale-up are high in Kenya, Uganda and
Burkina Faso, where the majority (respectively 92.7%,
77.5% and 71.4%) of respondents reported having
disclosed their HIV-positive status to their partners. The
disclosure rate is much lower in Malawi, where only one-
third of our respondents reported having disclosed to their
partners. Disclosure was positively associated in univarite
analysis with being older, living in urban areas, higher
education levels, and being male, while being negatively
associated with membership to support groups and pres-
ence of symptoms requiring treatment. The multivariate
analysis shows age, presence of symptoms requiring treat-
ment, membership to support groups and country of
recruitment to be independently associated to the preva-
lence of disclosure.
Table 3 Determinants of disclosure to partners
Variable uRR [95% CI] p value aRR [95% CI]1 p value aRR [95% CI]2 p value
Gender female 1 1 1
male 1.43 [1.18-1.75] <0.001 1.22 [1.02-1.46] 0.026 1.06 [0.87-1.31] 0.563
Age 1.01 [1.00-1.02] 0.042 1.01 [1.00-1.02] 0.017 1.01 [1.00-1.02] 0.030
Education <primary 1 1 1
> = primary 1.49 [1.21-1.85] <0.001 1.12 [0.90-1.40] 0.305 1.02 [0.81-1.29] 0.842
Setting of
recruitment
rural 1 1 1





no 1 1 1
yes 0.76 [0.58-0.99] 0.045 0.81 [0.62-1.06] 0.128 0.75 [0.58-0.98] 0.032
Self-stigma no 1 1 1




no 1 1 1
yes 0.52 [0.39-0.72] <0.001 0.65 [0.49-0.86] 0.003 0.67 [0.51-0.88] 0.004
Country of
recruitment
Malawi 1 n/a n/a 1
Kenya 2.84 [2.12-3.79] <0.001 n/a n/a 2.05 [1.49-2.82] <0.001
Uganda 2.37 [1.71-3.29] <0.001 n/a n/a 1.74 [1.21-2.50] 0.003
Burkina Faso 2.19 [1.54-3.10] <0.001 n/a n/a 1.89 [1.29-2.75] 0.001
Legend: uRR [95% CI]: unadjusted risk ratio and 95% confidence interval; aRR [95% CI]: adjusted risk ratio and 95% confidence interval; <primary: incomplete
primary education or no education; > = primary: complete primary education and above; n/a: not applicable. Adjusted RR are presented: 1 adjusted for country of
recruitment only; 2 multivariate model including gender, age, membership in support groups, and country of recruitment.
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sons to disclose to partners in all four countries. In some
cases, HIV-positive individuals wanted to protect their
partners from infection (the reason mentioned most by
women). In other cases, healthcare needs drove the dis-
closure process (mentioned more often by men). Both
men and women also referred to upholding the integrity
of their relationship as a reason to disclose to their part-
ner. The differences by gender in reasons to disclose
may be related to the fact that men more often test late,
when they are already sick. Women are tested more
often in PMTCT, when they are not yet sick.
One in four survey respondents scored positively on our
measures for self-stigma. But in our multivariate analysis,
self-stigma was not associated with disclosure. Self-stigma
was rarely referred to in the open-ended responses.
However, the disclosure narratives suggest that fear of
enacted stigma is an important reason for non-disclosure
for both men and women. Given the often negative reac-
tions HIV-positive individuals report when they disclose
to their partners, the fear of enacted stigma seems justi-
fied. Women reported more negative consequences than
men, though the stories also revealed changes in response
where negative reactions from partners became more
supportive over time.These findings have implications for PMTCT programs
which involve routine HIV testing and early treatment
initiation in antenatal care. Health workers routinely en-
courage HIV-positive pregnant women to refer their part-
ners for testing, though in reality this seems easier said
than done. As we have argued elsewhere, home-based
testing may be a more gender-neutral way of scaling up
HIV testing, as both men and women can be tested simul-
taneously at home [26].
Our interviews and focus group discussions with mem-
bers of support groups suggested that support groups
advocate caution when disclosing to partners. HIV-
positives should disclose when they are ‘ready’ to face the
consequences. In light of the negative partner responses
reported by many respondents, this makes sense. A key
finding of our multivariate analysis is that membership in
support groups is associated with lower levels of disclo-
sure to partners. This finding is independent of the
country of recruitment, gender, and education.
The current analysis has certain limitations. Its quali-
tative findings cannot be generalized. Small numbers of
HIV positive who answered the open ended questions
made it impossible to analyse subtle differences in dis-
closure dynamics by country. The gender dynamics that
we reported need to be further analysed in larger scale
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practices on partner disclosure. Women who test in
PMTCT are given different advice than men who test in
provider initiated testing and counselling (PITC) programs
in general health clinics. How do these different health care
constellations affect the observed differences in motiva-
tions to disclose?
The role of support groups in disclosure processes needs
to be further examined. Is the association observed be-
tween support group membership and non-disclosure
caused by a tendency of people who fear enacted stigma
to attend these groups? A study in five African countries
found that individuals participating in regular support
groups reported experiencing greater stigma (the study
treated enacted and feared stigma as one). The study hy-
pothesized experienced stigma as a reason why people
participate in support groups in the first place [34].
Finally, our mixed-methods study was unable to explain
the differences observed in partner disclosure rates be-
tween countries due to our inability to stratify the analysis
(small sample size). Why are they lower in Malawi than in
the other three countries? We suspect that differences in
HTC – both in policy and in how services are delivered –
might be important part of the story. Counsellors in
Malawi possibly place less emphasis on partner disclosure,
or gender relations may be different in the country. Future
mixed-methods studies should combine measurement of
disclosure rates with observation of counselling practices
on the ground, with more attention for gender relations
and kinship dynamics.
We also recommend that future studies follow longitu-
dinal designs to better grasp the dynamics that affect
disclosure to partners. New models are needed to under-
stand how (fear of) enacted stigma is associated with,
becoming members of support groups and partner dis-
closure. Our qualitative findings reveal that women often
face negative responses when they disclose and that their
fear of enacted stigma might be justified, in their indivi-
dual stories. Further questions include - what role do sup-
port groups play? And how they protect people from the
risks of enacted stigma?
Conclusion
Disclosure dynamics are context-specific. They are in-
fluenced by the practices of healthcare providers and sup-
port groups, by cultural views on HIV/AIDS as well as by
kinship dynamics and gender relations. Qualitative studies
are needed to better understand how contextual factors
affect partner disclosure.
Understanding the dynamics of partner disclosure
has become crucial now that Treatment as Prevention
programs (involving the early initiation of ART) are
being scaled-up in Sub-Saharan African settings for
sero-discordant couples. As disclosure tends to bemotivated by both the need for support for oneself as
well as caring about the partner’s well-being, the mes-
sage that treatment has benefits for both partners is
worth emphasizing. Support groups may prove suit-
able venues for discussing the benefits of treatment
not only for one’s own health but also one’s sexual
partner. Their role in supporting people to initiate
early treatment and disclose to partners should be
stressed more in scaling up HIV testing and antiretro-
viral treatment.
We have pointed to the prevailing gender dynamics in
access to HIV testing. Women tend to be tested early in
PMTCT programs, while men come late for testing when
they are already ill. As a result women tend to be bur-
dened with the need to disclose. Elsewhere we have
argued for home-based testing to overcome this gender
inequality in access to HIV testing and disclosure burden
[26,35]. Home-based testing enables simultaneous testing
of sexual partners in the privacy of their homes, creating
an opportunity for post-test couple counselling in which
the benefits of treatment for both the HIV positive and
the HIV negative partner can be emphasized.
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